HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Li Selected Research

BI 2536

1/2017Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer.
12/2015Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer.
5/2015Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Li Research Topics

Disease

815Neoplasms (Cancer)
12/2022 - 01/2002
153Neoplasm Metastasis (Metastasis)
09/2022 - 06/2002
135Breast Neoplasms (Breast Cancer)
04/2022 - 01/2002
133Infections
11/2022 - 06/2002
131Inflammation (Inflammations)
10/2022 - 05/2003
118Hepatocellular Carcinoma (Hepatoma)
10/2022 - 02/2002
80Carcinogenesis
08/2022 - 01/2002
60Hypoxia (Hypoxemia)
04/2022 - 06/2002
59Stroke (Strokes)
04/2022 - 10/2002
51Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 11/2008
48Lung Neoplasms (Lung Cancer)
08/2022 - 01/2005
48Wounds and Injuries (Trauma)
06/2022 - 01/2003
47Ovarian Neoplasms (Ovarian Cancer)
03/2022 - 08/2010
46COVID-19
11/2022 - 01/2020
45Carcinoma (Carcinomatosis)
03/2022 - 06/2002
44Fibrosis (Cirrhosis)
04/2022 - 03/2009
43Stomach Neoplasms (Stomach Cancer)
10/2022 - 09/2007
39Hypertension (High Blood Pressure)
08/2022 - 01/2004
38Prostatic Neoplasms (Prostate Cancer)
12/2022 - 12/2004
38Pain (Aches)
10/2022 - 06/2007
38Colorectal Neoplasms (Colorectal Cancer)
09/2022 - 05/2003
38Glioma (Gliomas)
06/2022 - 07/2004
38Pancreatic Neoplasms (Pancreatic Cancer)
04/2022 - 08/2007
35Obesity
04/2022 - 03/2008
34Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 01/2013
33Insulin Resistance
06/2022 - 05/2002
33Adenocarcinoma
01/2022 - 02/2003
31Ischemic Stroke
05/2022 - 09/2004
30Parkinson Disease (Parkinson's Disease)
04/2022 - 01/2002
30Alzheimer Disease (Alzheimer's Disease)
02/2022 - 06/2004
28Type 2 Diabetes Mellitus (MODY)
08/2022 - 05/2002
28Ischemia
04/2022 - 10/2002
27Body Weight (Weight, Body)
01/2022 - 02/2005
25Necrosis
06/2022 - 12/2010
25Leukemia
01/2022 - 02/2007
25Atherosclerosis
11/2021 - 01/2007
24Disease Progression
01/2022 - 01/2009
23Colonic Neoplasms (Colon Cancer)
12/2021 - 06/2008
23Infarction (Infarctions)
10/2021 - 10/2002
23Glioblastoma (Glioblastoma Multiforme)
01/2021 - 05/2005
22Asthma (Bronchial Asthma)
06/2022 - 01/2014
22Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2002
21Osteoporosis
03/2022 - 12/2009
20Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022 - 07/2009
20Liver Neoplasms (Liver Cancer)
06/2022 - 06/2002
20Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 01/2011
19Chronic Obstructive Pulmonary Disease (COPD)
07/2022 - 09/2010
19Reperfusion Injury
02/2022 - 11/2005
19Heart Failure
01/2022 - 12/2010
18Lymphatic Metastasis
01/2022 - 11/2008
17Mitochondrial Diseases (Mitochondrial Disease)
10/2022 - 08/2014

Drug/Important Bio-Agent (IBA)

282Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2002
176Biomarkers (Surrogate Marker)IBA
11/2022 - 03/2003
144Pharmaceutical PreparationsIBA
12/2022 - 03/2002
111MicroRNAs (MicroRNA)IBA
08/2022 - 07/2010
100Messenger RNA (mRNA)IBA
10/2022 - 01/2002
97Biological ProductsIBA
03/2022 - 01/2006
63Glucose (Dextrose)FDA LinkGeneric
05/2022 - 05/2002
59Long Noncoding RNAIBA
10/2022 - 01/2014
58CytokinesIBA
05/2022 - 12/2002
56EnzymesIBA
08/2022 - 07/2002
49RNA (Ribonucleic Acid)IBA
10/2022 - 06/2002
49DNA (Deoxyribonucleic Acid)IBA
06/2022 - 10/2003
42Therapeutic UsesIBA
06/2022 - 05/2003
38Cisplatin (Platino)FDA LinkGeneric
05/2022 - 05/2003
38Oxygen (Dioxygen)IBA
01/2022 - 12/2009
37LipidsIBA
05/2022 - 05/2003
37Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2002
33Phosphotransferases (Kinase)IBA
01/2022 - 05/2003
32Small Interfering RNA (siRNA)IBA
12/2022 - 09/2009
32Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 11/2006
32Interleukin-6 (Interleukin 6)IBA
06/2022 - 12/2007
32Transcription Factors (Transcription Factor)IBA
01/2022 - 04/2002
31Insulin (Novolin)FDA Link
08/2022 - 05/2002
31Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022 - 09/2003
30AntioxidantsIBA
06/2022 - 08/2006
30CateninsIBA
01/2022 - 08/2011
29CollagenIBA
04/2022 - 04/2002
29AntibodiesIBA
01/2022 - 05/2003
28Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 06/2005
27VaccinesIBA
11/2022 - 12/2002
27AntigensIBA
11/2022 - 08/2004
26Peptides (Polypeptides)IBA
12/2022 - 06/2004
25Indicators and Reagents (Reagents)IBA
01/2022 - 01/2008
22Doxorubicin (Adriamycin)FDA LinkGeneric
12/2022 - 12/2005
21CholesterolIBA
01/2022 - 01/2004
20Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2021 - 10/2004
19UbiquitinIBA
10/2022 - 03/2005
18LipopolysaccharidesIBA
10/2022 - 09/2010
18Adenosine Triphosphate (ATP)IBA
10/2022 - 06/2008

Therapy/Procedure

372Therapeutics
10/2022 - 10/2002
140Drug Therapy (Chemotherapy)
09/2022 - 11/2003
65Radiotherapy
09/2022 - 08/2003
54Immunotherapy
10/2022 - 02/2003
33Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2022 - 09/2007
25Lasers (Laser)
01/2022 - 10/2002
23Transplantation
12/2021 - 08/2003
22Neoadjuvant Therapy
05/2022 - 01/2008
20Aftercare (After-Treatment)
03/2022 - 10/2004
17Precision Medicine
12/2022 - 01/2014